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Abstract
Background: The incidence of dengue hemorrhagic fever is increasing among the adult population living in
endemic areas. The disease carries a 0.73% fatality rate for the general population, but what happens when the
disease strikes a special subpopulation group, the obstetrics? Perhaps the important question specific to this special
subpopulation revolves around the right time and mode of delivery under severe coagulopathy and plasma
leakage in conditions of imminent delivery.
Case presentation: A 24-year-old primigravid Sundanese woman presented to our intensive care unit due to acute
pulmonary edema secondary to massive plasma leakage caused by severe dengue. She tested positive for both
immunoglobulin G and immunoglobulin M dengue serology indicating she had secondary dengue infection, which
placed her at risk for an exaggerated cytokine response as was evident clinically. She had to undergo an
emergency cesarean section which was later complicated by rebleeding and hemodynamic instability due to an
atypical defervescence period. She was successfully managed by multiple blood transfusions and was discharged
from our intensive care unit on day 8 without any negative sequel.
Conclusions: Fever, thrombocytopenia, and hemoconcentration are the classical symptoms of dengue
hemorrhagic fever observed in adult, pediatric, and obstetric populations. However, a clinician must be particularly
watchful in treating a pregnant dengue-infected patient as physiologic hematology changes provide greater
volume compensation and the advent of shock marks significant volume loss. In conclusion, an important principle
in the management of dengue hemorrhagic fever in pregnancy is to prioritize maternal well-being prior to
addressing fetal issues.
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Background
Dengue is a common tropical infectious disease with a
rising incidence among the Indonesian population. In
2013, its annual incidence was reported to be 35 to 40/
100,000 with a mean age of above 15-years old and a
case fatality rate of 0.73% [1]. The classical form of den-
gue infection is manifested as high fever, violent head-
aches, thrombocytopenia, and hemoconcentration. Such
presentations are similar to those within the obstetric
population; however, bleeding tendency is increased es-
pecially for both the mother and the neonate due to
hemostatic defects which might lead to uncontrolled
bleeding [2].
The management of dengue hemorrhagic fever during
pregnancy warrants careful monitoring as physiologic
hemodilution may mask hemoconcentration leading to
late diagnosis and late management of the severely
volume-depleted patient. Plasma leakage accumulates
along the tissue interstitial space and causes inadequate
tissue oxygenation. Prolonged disturbance may develop
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into multiorgan failure and rapid fetal demise especially
in the obstetric population where oxygen consumption
is twice as high as the healthy adult [3].
Fluid therapy and identification of the critical phase
are the most important aspects of management, but
what does clinical evidence say about dengue infection
in the obstetric population? Diagnosis of dengue infec-
tion during pregnancy surely affects management op-
tions and decisions as the mode and time of delivery are
of utmost importance. In this case report, we will discuss
the pathophysiology and management of severe dengue
hemorrhagic fever and bleeding complications in an in-
tensive care unit (ICU).
Case presentation
A 24-year-old Sundanese primigravid woman was referred
from a peripheral hospital at 38 weeks of gestation due to
her deteriorating condition. She presented initially for
5 days of high grade fever, retro-orbital pain, and a blood
examination which revealed thrombocytopenia, elevated
liver enzymes, and a positive immunoglobulin M (IgM)
and immunoglobulin G (IgG) dengue serology. She was
diagnosed as having dengue fever in pregnancy and
treated with fluid administered intravenously and antipy-
retics. However, her condition started to worsen on day
five of hospitalization with repeated bouts of vomiting and
she became lethargic. Her weight was 45 kg and her ante-
natal history did not reveal hypertension, pre-eclampsia,
coagulation abnormalities, or epilepsy.
During her transport, she received 10 liters of oxygen
by non-rebreathing mask and had experienced two epi-
sodes of generalized tonic–clonic seizure, each lasting
less than 1 minute which terminated with 10 mg diaze-
pam administered intravenously. On admission to our
ICU, she was responsive only to pain with a blood pres-
sure of 92/76 mmHg, heart rate 124/minute, respiratory
rate 30/minute, body temperature 36.6 °C, and oxygen
saturation of 95%. A physical examination revealed dif-
fuse rales on both lungs with cold and clammy extrem-
ities. Her chest X-ray revealed marked bronchovascular
marking on her left and right basal lung regions (Fig. 1).
Arterial blood gas analysis revealed an acute metabolic
alkalosis: pH 7.510, partial pressure of oxygen in arterial
blood (PaO2) 166 mmHg, partial pressure of carbon diox-
ide in arterial blood (PaCO2) 41.3 mmHg, bicarbonate
(HCO3
-) 33.0 mmol/L, and base excess (BE) 9.3 mmol/L.
An initial diagnosis of dengue encephalitis, and dengue
shock syndrome with acute pulmonary edema was made.
She was immediately intubated and placed on mech-
anical ventilation using adaptive support ventilation
mode with the following settings: minute ventilation of
4.5 L, positive end-expiratory pressure (PEEP) 5 cmH2O,
and fraction of inspired oxygen (FiO2) of 50% and
received continuous sedation under morphine and
midazolam infusion. During anesthesia induction, her
blood pressure dropped to 60/40 mmHg and a fluid
bolus of 300 mL normal saline was given to which she
responded. Arterial blood gas analyses taken 2 hours
post-intubation with a FiO2 0.7 were as follows:
pH 7.475, PaO2 159.1 mmHg, PaCO2 32.1 mmHg,
HCO3
- 24.2 mmol/L and BE 1.1 mmol/L. Another im-
portant event included traumatic gum bleeding from bit-
ing during her seizure episode which took 1 hour to
attain hemostasis, and insertion of a nasogastric tube
which yielded 100 mL of dark brown fluid.
On day 1, hematologic results revealed hemoglobin
(Hgb) of 11.7 g/dL (normal range, N, 11.70 to 15.50 g/dL),
hematocrit (Hct) of 36.80% (N, 35.00 to 47.00), and white
cell count (WBC) of 10,430/mm3 (N, 3600 to 11,000/
mm3) with 53% neutrophil predominance and 35% lym-
phocytes. Her platelet (Plt) count was 25,000/uL (N,
150,000 to 440,000), prothrombin time (PT) 10.40 seconds
(N, 9.4 to 11.3) with an international normalized ratio
(INR) of 1.00, activated partial thromboplastin time
(aPTT) of 48.70 (N, 31 to 45 seconds), and a slightly
elevated D-dimer of 1.91 ng/mL (N, 0.00 to 0.30). Her bili-
rubin levels were normal, she had an alanine aminotrans-
ferase (ALT) level of 116 U/L (N, 0 to 55), aspartate
transaminase (AST) of 359 U/L (N, 5 to 34), urea of
49.0 mg/dL (N, <50), creatinine of 0.85 mg/dL (N, 0.5 to
1.1), lactic acid of 4.7 mmol/L (N, <0.6 to 2.2) and procal-
citonin of 0.25 ng/mL (N, <0.15). Her urine was tinted red
and complete analysis revealed the presence of slight
proteinuria (100 mg/dL) and occult blood (200 cells/uL).
Cardiotocography (CTG) monitoring revealed a fetal heart
rate of 177 beats per minute (bpm) with no uterine
contractions.
On day 2, a routine CTG monitoring revealed fetal
distress which prompted an emergency cesarean section.
She received 500 mL fresh frozen plasma (FFP) before
being rushed for cesarean section under general anesthesia.
Intraoperative bleeding was 500 mL, an intra-abdominal
drain was placed and she received 460 mL of packed
red cell (PRC), intraoperatively. A 2.1 kg baby girl was de-
livered with an appearance, pulse, grimace, activity and
respiration (APGAR) score of 4/7. The baby was intubated
and transferred to our neonatal ICU (NICU) due to
hypoventilation. Our patient was transferred back to ICU
and fundal height was noted at the level of umbilicus with
good contractions.
On day 3, blood clots were seen oozing from her vagina
and a vaginal exploration evacuated 200 mL of blood. The
intra-abdominal drain collected 50 mL/24 hours of
hemoserous fluid and hematologic results revealed Hgb
5.9 g/dL, Hct 18.20%, and Plt 141,000/uL. Upon this sub-
stantial drop, 680 mL of PRC, 210 mL of FFP, and 2 units
of thrombocyte concentrate apheresis (TCA) were given.
Her vital parameters were stable and she remained sedated.
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A follow-up chest radiography revealed improved clearance
of vascular markings on both lung fields confirmed by
vesicular lung sounds and a normal acid-base balance with
a PaO2/FiO2 of 600 (Fig. 2).
On day 4, a follow up hematologic examination re-
vealed Hgb 6.96 g/dL, Hct 20.16%, WBC 10,660/mm3,
Plt 98,630/uL, albumin 2.63 g/dL, fibrinogen 140 mg/dL
(N, 300 to 600), PT 10.90 seconds, and a prolonged
aPTT of 56.90 seconds. The intra-abdominal drain col-
lected 450 mL/24 hours of hemoserous fluid and her
lower abdomen was noted to be slightly distended.
Thereafter, another 230 mL of PRC, 240 mL of FFP, and
2 units of thrombocyte concentrate (TC) was transfused.
On day 5, 3 days post-cesarean section, our patient be-
came tachycardic with a blood pressure of 80/60 mmHg,
which prompted the use of norepinephrine at 0.08 μg/
kg/minute. Uterine contractions were adequate with
normal colored lochia, but her lower abdomen appeared
distended as before. The intra-abdominal drain collected
360 mL/24 hours of hemoserous fluid and laboratory
results were as follow: Hgb 5.90 g/dL, Hct 17.80%,
WBC14,020/mm3, Plt 107,000/uL, and albumin of
2.26 g/dL. She was given 20% albumin infusion, 230 mL
of PRC, and 220 mL of FFP.
On day 6, she remained tachycardic and her mentation
did not improve despite stopping sedation. At this time,
her lower abdomen appeared more distended and ab-
dominal guarding was noted upon palpation. The intra-
abdominal drain had collected 850 mL/24 hours of hemo-
serous fluid. An urgent blood workup revealed a drop in
Hgb to 4.20 g/dL, Hct 12.50%, WBC 10,160/mm3, Plt
84,000/uL, PT 10.40 seconds, aPTT 49.50 seconds,
and a spiked D-dimer level (20.25 ug/mL). An emergent
ultrasound revealed free fluid on her lower abdominal
region which required her to be rushed for an exploratory
laparotomy. The procedure evacuated 2000 mL of blood
intra-abdominally, and she received 640 mL of PRC and
500 mL FFP, intraoperatively.
On day 7, her hematologic examination revealed Hgb
9.60 g/dL, Hct 28.50%, WBC 8,150/mm3, Plt 67,000/uL,
normalized coagulation profile, and a lowered D-dimer
level (13.98 ug/mL). One unit of TC was transfused and
norepinephrine infusion was tapered down with strict
vital sign monitoring. Sedation was stopped and her
mentation greatly improved. A follow-up chest radiograph
Fig. 1 Chest X-ray upon initial admission
Fig. 2 Chest X-ray on day 3 of hospitalization
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revealed clear lung fields and she was placed on a spon-
taneous breathing trial which was successful and she was
later extubated.
On day 8, an additional 230 mL PRC was given and
her hematologic examination revealed Hgb 11.50 g/dL,
Hct 34.40%, and Plt 83,000/uL. Aside from transfusions
and vasopressors, she received meropenem 1 gram every
8 hours, early enteral nutrition of 1000 kcal/24 hours,
gastric acid prophylaxis agent, gastric motility agents,
and anticonvulsants. She was transferred to our general
ward on day 8 and discharged from our hospital on day
11, uneventfully. Her neonate was extubated on day 2 of
her NICU stay, after complete recovery from sedative
drugs in utero and discharged home at day 5 without
any negative sequel (Table 1).
Discussion
Dengue infection presents with a febrile period of 2 to
7 days followed by 3 to 4 days of defervescence phase
marked by massive plasma leakage which may progress
to shock [4]. Recall that during pregnancy, the body ex-
periences physiologic changes with respect to the cardio-
vascular, respiratory, and hematologic systems [5]. At
the end of the third trimester, plasma volume increases
by approximately 40% resulting in dilutional anemia
which masks the ‘hemoconcentration’ commonly observed
during the defervescence phase of dengue hemorrhagic
fever. The finding is confirmed as our patient was at her
tenth day of illness. She was at the ‘critical’ phase of den-
gue infection with a normal Hct; nevertheless, she was in
a state of shock with altered mental status and reduced
perfusion.
Severe manifestations of dengue infection are reported
to be a combination of factors from the host, viral viru-
lence, and those presenting with secondary exposures
[6]. The dengue virus replicates intracellularly and car-
ries tropism to endothelial cells, pulmonary cells, and
gastrointestinal cells which triggers an antigen-antibody
complex causing immune-mediated cell destruction and
the production of cytokines and antibodies [7]. Our pa-
tient tested positive on IgG and IgM serology test, thus
categorizing her with secondary dengue infection, which
increases the risk for an exaggerated cytokine cascade
response; this response was made clinically evident by
severe thrombocytopenia (<50,000), elevated liver en-
zymes, mucosal bleeding, and massive plasma leakage
which contributed to the development of acute pulmon-
ary edema [8].
On arrival to our ICU, our patient was only responsive
to pain stimulation with significant tachypnea and la-
bored breathing. In pregnancy, the normal arterial pH is
7.45 with a PaCO2 of 30 mmHg due to increased minute
ventilation. Our patient revealed alkalosis with a rising
paCO2 level of 41.3 mmHg indicating that she was
Table 1 Daily hematology trend and therapy
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8
Therapy given prior
to blood test results
Packed red cell (mL) None 460 None None None None None 230
Thrombocyte concentrate
apheresis (Unit)
None None None None None None None None
Fresh frozen plasma (mL) None 500 None None None None None None
Hemogram Hemoglobin (g/dL) 11.7 13.3 5.9 6.96 5.9 4.2 9.6 11.5
Hematocrit (%) 36.8 41.9 18.2 20.16 17.8 12.5 28.5 34.4
White blood cell (/mm3) 10,430 10,690 11,390 10,660 14,020 10,160 8150
Platelets (/μL) 25,000 31,000 141,000 98,030 107,000 84,000 67,000 83,000
Coagulation studies Prothrombin time
(seconds)




48.7 46.1 51.7 56.9 55.2 49.5 45.6 41.5
D-dimer (μg/mL) 1.91 2.71 1.49 5.36 18.96 20.25 13.98 11.2
Fibrinogen (mg/dL) N/A N/A N/A 140 N/A N/A N/A N/A
Therapy given after
blood results
Packed red cell (mL) None None 680 230 230 640 None None
Thrombocyte concentrate
apheresis (Unit)
None None 2 2 None None 1 None
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developing fatigue marked by CO2 retention and im-
paired ventilation [5]. Marked vascular markings on
radiologic examination and crackles upon lung ausculta-
tion signify a potential disruption in the process of oxy-
genation. More importantly, the obstetric patient
requires a greater amount of oxygen to meet her basal
metabolic rate and every pregnant patient is considered
at risk for aspiration due to reduced gastric emptying
time [5]. For these reasons, she was intubated and sup-
ported by mechanical ventilation.
Perhaps the most important question to ask revolves
around the mode and timing of delivery of a severely
thrombocytopenic patient. Should delivery be performed
even before the onset of fetal distress and what are the
recommended guidelines on thrombocytopenia in preg-
nancy? Two units of FFP were transfused as recom-
mended by World Health Organization transfusion
guidelines prior to elective surgical procedures [9, 10].
We believe cesarean section performed on our patient
due to fetal distress was the appropriate decision. On
her arrival to our institution, optimization of maternal
status was aggressively pursued in order to provide opti-
mal oxygen delivery to the fetus. Unfortunately, the
fetus’s condition deteriorated which may have been a re-
sult of prior maternal hypoxemia and alkalotic condition
disrupting oxygen release to tissue. General anesthesia
was the preferred mode of delivery as neuraxial anesthesia
was impossible owing to our patient’s respiratory distress
and thrombocytopenia [11]. After the operation, she was
given 2 units of PRC and an intra-abdominal drain was
inserted in anticipation of bleeding diathesis.
Over the next few days, insidious bleeding occurred as
her Hgb substantially plummeted from 13.3 g/dL to
4.2 g/dL within 4 days. Even though thrombocytopenia
is universally observed in dengue hemorrhagic fever, it is
a poor indicator of bleeding manifestation. It is rather
the low fibrinogen levels and prolonged aPTT which are
the main culprits for coagulopathy [12]. Normal preg-
nancy is a state of hypercoagulopathy due to a physio-
logic increase in coagulation factors [13]. By contrast,
our patient had lowered fibrinogen levels and prolonged
aPTT. This is caused by increased vascular permeability
causing leakage of fibrinogen into the interstitial spaces
while pronounced cytokine response causes damage to
glycocalyx along the endothelial linings and liberates
heparin sulfate into the circulation, thereby disrupting
the intrinsic coagulation pathway [14]. Such disturbance
combined with a recent operative procedure triggered
the ongoing hemorrhage in our patient.
The critical phase of dengue hemorrhagic fever lasts 2
to 4 days, but our patient continued to face hemostatic de-
fects and volume depletion up to her sixth day. During
her secondary infection of dengue, the binding of the new
virus to cross-reactive antibodies from her previous
infection resulted in the uptake of virus into mononuclear
phagocytes. This enables the virus to amplify viral replica-
tion resulting in a higher viral antigen load and an exag-
gerated form of coagulopathies and vascular permeability
[7, 15]. The plasma leakage is caused by the functional
disruption of adherens junction, a network of adhesion
proteins in the intracellular cytoskeleton that retract and
create gaps between cells promoting leakage of plasma
and coagulation proteins, which is transient and resolves
itself as the cytokine response wears off [6].
Throughout the course of her ICU stay, our patient re-
ceived a total of 11 units of PRCs, 7 units of FFP, 2 units
of TCA, and 3 units of TC. Apart from blood product
transfusions, treatment of severe dengue hemorrhagic
fever includes judicious fluid therapy during the ‘critical’
phase to avoid leakage of fluids into the fragile pulmon-
ary capillaries. Hence, we used 20 ml/hour of normal sa-
line infusion while striving for zero fluid balance and
maintaining a diuretic goal of 1 mL/kg/hour. Stable vital
signs, clearance of vascular markings on the chest X-ray,
and a normalized PaO2/FiO2 ratio indicated appropriate
fluid titration in our patient.
Conclusions
Current evidence has reported similarities in symptoms
and laboratory findings in the obstetric population in-
fected by dengue hemorrhagic fever. However, clinicians
must be aware that secondary dengue infections may
manifest an atypical period of defervescence phase
marked by severe prolonged coagulopathies and plasma
leakage. Hence, the management of dengue-infected ob-
stetric patients is aimed at conservative fluid therapy
and transfusion of blood product when signs of bleeding
occur. An important principle to remember is to
prioritize maternal well-being prior to addressing fetal
issues. Next, a delivery plan via the fastest route and
timely administration of blood products prior to delivery
is essential in order to deliver the most beneficial out-
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